{
    "Trade/Device Name(s)": [
        "HemoCue HbA1c 501 Glycosylated Hemoglobin Monitoring System"
    ],
    "Submitter Information": "Infopia Co., Ltd.",
    "510(k) Number": "K141750",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121366"
    ],
    "Regulatory Class": "",
    "Product Code(s)": [],
    "Summary Letter Date": "",
    "Summary Letter Received Date": "",
    "Submission Date": "",
    "Regulation Number(s)": [],
    "Regulation Name(s)": [],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glycosylated Hemoglobin (HbA1c)"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Infopia's HemoCue HbA1c 501 system modifications for usability improvements and additional device functions",
    "Indications for Use Summary": "Intended use for monitoring glycosylated hemoglobin remains unchanged from the predicate device",
    "fda_folder": "Hematology"
}